Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

ClinicalTrials.gov ID: NCT06989359

Public ClinicalTrials.gov record NCT06989359. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 19, 2026, 9:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Study to Assess ADX-038 in Participants With Complement-Mediated Kidney Disease

Study identification

NCT ID: NCT06989359
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: ADARx Pharmaceuticals, Inc.; Industry
Enrollment: 45 participants

Conditions and interventions

Conditions

Interventions

ADX-038 Dose Level 1 Drug
ADX-038 Dose Level 2 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 27, 2025
Primary completion: Dec 30, 2028
Completion: May 31, 2029
Last update posted: Apr 21, 2026

2025 – 2029

United States locations

U.S. sites: 11
U.S. states: 8
U.S. cities: 11

Facility	City	State	ZIP	Site status
ADARx Clinical Site	Doral	Florida	33122	Recruiting
ADARx Clinical Site	Miami	Florida	33127	Recruiting
ADARx Clinical Site	Pembroke Pines	Florida	33029	Recruiting
ADARx Clinical Site	Iowa City	Iowa	52242	Recruiting
ADARx Clinical Site	Shreveport	Louisiana	71101	Recruiting
ADARx Clinical Site	Shelby	Michigan	48315	Recruiting
ADARx Clinical Site	Great Neck	New York	11021	Recruiting
ADARx Clinical Site	Columbus	Ohio	43210	Recruiting
ADARx Clinical Site	Dakota Dunes	South Dakota	57049	Recruiting
ADARx Clinical Site	Dallas	Texas	75230	Recruiting
ADARx Clinical Site	Houston	Texas	77027	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06989359, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 21, 2026 · Synced May 19, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06989359 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →